By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sciele Pharma, Inc. 

Five Concourse Parkway
Suite 1800
Atlanta  Georgia  30328  U.S.A.
Phone: 800-461-3696 Fax:



Company News
Shionogi Pharma, Inc. to Halve US Sales Force as Generics Hit Former Sciele Pharma, Inc. (SCRX) Business 9/8/2010 11:50:49 AM
Sciele Pharma, Inc. (SCRX), a Shionogi Group Company, Announces Name Change to Shionogi Pharma, Inc. 1/12/2010 11:14:55 AM
Sciele Pharma, Inc. (SCRX) Introduces Adrenaclick(TM) (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis 1/7/2010 10:10:09 AM
Pivotal Study For Sciele Pharma, Inc. (SCRX)'s PSD502 -- The First Potential Treatment For Premature Ejaculation 11/19/2009 7:35:41 AM
Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company 11/16/2009 10:36:14 AM
Sciele Pharma, Inc. (SCRX) Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients 9/28/2009 10:08:18 AM
Sciele Pharma, Inc. (SCRX) Announces Availability of ULESFIA(TM) 8/5/2009 9:12:33 AM
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation 7/29/2009 9:44:44 AM
Sciele Pharma, Inc. (SCRX) Says Scraps $150 Million Plan to Buy Victory Pharma, Inc. 7/10/2009 6:41:56 AM
Sciele Pharma, Inc. (SCRX) Announces Availability of Ulesfia (Benzyl Alcohol Lotion 5%), First Prescription Non-Neurotoxic Head Lice Treatment 7/9/2009 9:15:40 AM